Saturday, 10 October 2026 Updated 54 min ago
The News Engine
Latest
Science United States

FDA-approved epilepsy drug may help reverse osteoarthritis damage

Researchers at Yale have identified a promising new approach to osteoarthritis that could do more than simply ease pain.

According to ScienceDaily, researchers at Yale have identified a promising new approach to osteoarthritis that could do more than simply ease pain.

The epilepsy drug lacosamide appears to block a protein involved in both pain signaling and cartilage destruction, helping damaged joints shift back toward repair in preclinical studies.

This science story centres on the United States.

Why it matters

Scientific work like this adds to what we know and can inform future research, policy and technology.

Key details

Location
United States · Americas
Reported by
ScienceDaily
First reported
Key names
Yale
Section
Science

Sources

This is an independent summary. Read the full, original reporting from the publisher:

Read the full story at ScienceDaily

Spotted an error? Request a correction · How this summary was produced

Related Stories